Literature DB >> 11406717

GB virus B as a model for hepatitis C virus.

B Beames1, D Chavez, R E Lanford.   

Abstract

GB viruses A and B (GBV-A and GBV-B) are members of the Flaviviridae family and are isolated from tamarins injected with serum from a human hepatitis patient. Along with a related human virus, GB virus C, or alternatively, hepatitis G virus (GBV-C/HGV), the three viruses represent the GB agents. Of the three viruses, GBV-B has been proposed as a potential surrogate model for the study of hepatitis C virus (HCV) infections of humans. GBV-B is phylogenetically most closely related to HCV and causes an acute, self-resolving hepatitis in tamarins as indicated by an increase in alanine aminotransferase and changes in liver histology. Similarities between GBV-B and HCV are found at the nucleotide sequence level with the two viruses sharing 28% amino acid homology over the lengths of their open reading frames. Short regions have even higher levels of homology that are functionally significant as shown by the ability of the GBV-B NS3 protease to cleave recombinant HCV polyprotein substrates. The shared protease substrate specificities suggest that GBV-B may be useful in testing antiviral compounds for activity against HCV. Although there are numerous similarities between GBV-B and HCV, there are important differences in that HCV frequently causes chronic infections in people, whereas GBV-B appears to cause only acute infections. The acute versus chronic course of infection may point to important differences between the two viruses that, along with the numerous similarities, will make GBV-B in tamarins a good surrogate model for HCV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406717     DOI: 10.1093/ilar.42.2.152

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  28 in total

1.  Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.

Authors:  Christophe Hourioux; Malika Ait-Goughoulte; Romuald Patient; Delphine Fouquenet; Fabienne Arcanger-Doudet; Denys Brand; Annette Martin; Philippe Roingeard
Journal:  Cell Microbiol       Date:  2006-12-06       Impact factor: 3.715

2.  Hepatic immunopathology during occult hepacivirus re-infection.

Authors:  Cordelia Manickam; Amanda J Martinot; Rhianna A Jones; Valerie Varner; R Keith Reeves
Journal:  Virology       Date:  2017-09-13       Impact factor: 3.616

Review 3.  The Strange, Expanding World of Animal Hepaciviruses.

Authors:  Alex S Hartlage; John M Cullen; Amit Kapoor
Journal:  Annu Rev Virol       Date:  2016-09-29       Impact factor: 10.431

4.  A mouse model for hepatitis C virus infection: are we there yet?

Authors:  Cordelia Manickam; R Keith Reeves
Journal:  Ann Infect       Date:  2017-11-30

Review 5.  Hepatitis C virus experimental model systems and antiviral drug research.

Authors:  Susan L Uprichard
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

6.  Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction.

Authors:  Selena M Sagan; Peter Sarnow; Joyce A Wilson
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

7.  Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.

Authors:  Xuemei Yu; Bruno Sainz; Susan L Uprichard
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

8.  The marmoset model of GB virus B infections: adaptation to host phenotypic variation.

Authors:  Trudie Weatherford; Deborah Chavez; Kathleen M Brasky; Robert E Lanford
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  Hallmarks of hepatitis C virus in equine hepacivirus.

Authors:  Tomohisa Tanaka; Hirotake Kasai; Atsuya Yamashita; Kaori Okuyama-Dobashi; Jun Yasumoto; Shinya Maekawa; Nobuyuki Enomoto; Toru Okamoto; Yoshiharu Matsuura; Masami Morimatsu; Noboru Manabe; Kazuhiko Ochiai; Kazuto Yamashita; Kohji Moriishi
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

10.  Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck.

Authors:  Trudie Weatherford; Deborah Chavez; Kathleen M Brasky; Stanley M Lemon; Annette Martin; Robert E Lanford
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.